English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

It has been assumed that low birth weight and high placenta weight were key factors for predicting hypertension in human adulthood. Adeficiency in placental 11β-HSD-II enzyme activity was supposed to be the underlying cause. To possibly establish 11β-HSD-II as a leading factor, we determined 11β-HSD-II activities in 133 healthy pregnancies, 21 proteinuric pregnancies complicated by pregnancy-induced hypertension (PIH), 26 non proteinuric PIH pregnancies and 15 pregnancies complicated by fetal growth restriction (32 nd –41 st  gestational week). We could not identify differences in 11β-HSD-II activity between pregnancies with the rare combination of small babies with big placentas and others (p 5 0,59; Kruskal-Wallis test). And although there was no correlation between 11β-HSD-II activity and birth weight, in the control gestational age correlated with 11β-HSD-II activity (r = 0,22; p &lt; 0.05; Spearman).

journal of perinatal medicine

11β-hydroxysteroid dehydrogenase (11β-HSD-II) activity in human placenta: Its relationship to placental weight and birth weight and its possible role in hypertension